The active compound of Molnupiravir, N4-hydroxycyt... (ID 1009582) - BioProject

Format

Choose Destination

Accession: PRJEB65430 ID: 1009582

The active compound of Molnupiravir, N4-hydroxycytidine, promotes SARS-CoV-2 mutagenesis

N4-hydroxycytidine (NHC), the active compound of Molnupiravir, was used to treat SARS-CoV-2-infected cells. More...

Accession	PRJEB65430
Scope	Monoisolate
Submission	Registration date: 26-Aug-2023 university of applied sciences koblenz

Project Data:

Parameter	Value
Data volume, Gbases	122
Data volume, Mbytes	47747

Supplemental Content

The active compound of Molnupiravir, N4-hydroxycytidine, promotes SARS-CoV-2 mut...
The active compound of Molnupiravir, N4-hydroxycytidine, promotes SARS-CoV-2 mutagenesis
The active compound of Molnupiravir, N4-hydroxycytidine, promotes SARS-CoV-2 mutagenesis

BioProject
Homo sapiens rearranged Ig heavy chain variable region, isolate cell D2/11/27+
Homo sapiens rearranged Ig heavy chain variable region, isolate cell D2/11/27+
gi|3646196|emb|AJ231601.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.